688739.SS
688739.SS
CNE100004ZP2
LIAONING CHENGDA BIOTECHNOLOGY
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
8.83B EUR
8.12B EUR
10.25B EUR
10.73B EUR
Enterprise Value
3.59B EUR
4.53B EUR
6.57B EUR
6.37B EUR
Valuation Multiples
Trailing P/E
212x
31,352.34x
676.89x
120.17x
Forward P/E
39.26x
--
--
--
Price to Sales
6.49x
8.35x
11.19x
10.72x
Price to Book
0.93x
0.87x
1.1x
1.15x
EV/Revenue
2.64x
4.66x
7.17x
6.36x
EV/EBITDA
18.88x
47.37x
75.61x
38.52x
Price to FCF (P/FCF)
--
83.73x
151.7x
185.21x
EV/FCF
--
46.74x
97.21x
110.02x
FCF Yield
-0.7%
1.19%
0.66%
0.54%
ende